About Mirna Therapeutics

Mirna Therapeutics, Inc. (Mirna) is a biopharmaceutical biotechnology research and development company focused on miRNA-directed oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and a broad IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics. Read more >

About microRNA

microRNAs (miRNAs) are small, non-coding RNA molecules that occur naturally in human cells. Misregulation of these critical cellular components is a frequent event in the development of genetically manifested human disease. Mirna Therapeutics is developing treatments that have the promise of being effective in humans by restoring normal miRNA function. Read more >

About miRNA Replacement Therapy

miRNA Replacement Therapy is a new approach to treat human disease. It involves the re-introduction of a synthetic version of a miRNA that is depleted in the diseased tissue. Since the synthetic and the natural miRNA are virtually indistinguishable, miRNA-based therapeutics have the potential of not exhibiting non-specific side effects. The synthetic miRNA counteracts disease-dependent processes and induces a therapeutic response. Read more >